.
following close on aimovig's heels are three other drugs that target cgrp: fremanezumab, galcanezumab, and eptinezumab (which is given by iv).
.
.
.
it's the first successful medical treatment of a human fetus for the underlying cause of a genetic disorder, experts say
.